Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2026)

Amphastar Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $9.7 million for Q1 2026.

• In Q1 2026, Current Leases rose 25.29% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $9.7 million (up 25.29% YoY), while the FY2025 annual figure was $7.9 million, up 16.52% from the prior year.
• Current Leases was $9.7 million for Q1 2026 at Amphastar Pharmaceuticals, up from $7.9 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $9.7 million in Q1 2026 to a low of $3.0 million in Q1 2023.
• Historically, Current Leases has averaged $5.1 million across 5 years, with a median of $3.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Current Leases fell 11.43% in 2022, then jumped 97.17% in 2025.
• A 5-year view of Current Leases shows it stood at $3.0 million in 2022, then soared by 30.07% to $3.9 million in 2023, then surged by 74.19% to $6.8 million in 2024, then climbed by 16.52% to $7.9 million in 2025, then rose by 22.41% to $9.7 million in 2026.
• The last three Current Leases figures came in at $9.7 million (Q1 2026), $7.9 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.